secwatch.observer — SEC 8-K summary
======================================

Issuer:     iBio, Inc. (IBIO)
CIK:        0001420720
Form:       8-K
Filed at:   2024-06-03T23:59:59+00:00
Accession:  0001558370-24-008860
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iBio updates corporate presentation; no financial or operational specifics disclosed
--------------------------------------------------------------------------------

- Filed updated investor presentation dated June 2024 under Item 7.01.
- Presentation title: 'Tomorrow's Precision Antibody Therapeutics Powered by Machine Learning'.
- No new financial data, guidance, or material business changes were included in the filing.
- The presentation is furnished, not filed, and not incorporated by reference.
- No forward-looking statements or new milestones were provided beyond prior disclosures.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1420720/000155837024008860/0001558370-24-008860-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1420720/000155837024008860/ibio-20240603x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-008860

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer